Back |
home / stock / gtbp / gtbp message board
Subject | By | Source | When |
---|---|---|---|
Bidding $2.49 here | Disquisition | investorshub | 02/24/2021 1:03:17 AM |
i have been there before ! most reverse | ShortSale4U | investorshub | 02/23/2021 6:38:50 PM |
i have been there before ! most reverse | ShortSale4U | investorshub | 02/23/2021 6:38:43 PM |
With phase I coming to an end by | OilRush | investorshub | 02/16/2021 3:37:02 PM |
Today was a solid return. I expect many | Sage7243 | investorshub | 02/13/2021 12:12:59 AM |
If you have a small position that would | Jacque_Strap | investorshub | 02/12/2021 4:57:48 AM |
I currently have a small position but am | Sage7243 | investorshub | 02/12/2021 1:08:47 AM |
I dont think so. Its obvious your a shorter and | Jacque_Strap | investorshub | 02/11/2021 11:56:53 PM |
Good choice. They raised well over $20,000,000. Going forward there | Jacque_Strap | investorshub | 02/11/2021 11:55:12 PM |
I have been waiting for the uplist and | Sage7243 | investorshub | 02/11/2021 10:23:33 PM |
This could be good news vs bad news | Jacque_Strap | investorshub | 02/11/2021 4:37:53 PM |
you all just got taken. This will be | ShortSale4U | investorshub | 02/11/2021 2:54:18 PM |
News, Short Squeeze, Breakout and More Instantly...
IND clearance for GTB-3650, a 2 nd generation nanobody TriKE ® for treatment of CD33+ leukemia expected in Q2 2024 Phase 1 trial initiation with GTB-3650 expected in 2H 2024 Anticipate IND submission for GTB-5550 TriKE ® for treatment ...
Remain in active dialogue with the FDA regarding IND clearance for GTB-3650, a 2 nd generation nanobody TriKE ® for treatment of CD33+ leukemia Phase 1 trial with GTB-3650 anticipated to start in 2H 2024 Anticipate submitting an IND for GTB-5550 target...
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adj...